How we score providers
Every provider is scored against the published v3.0 six-pillar rubric (100 points total), applied uniformly. Read the full methodology →
All 10 providers reviewed
NexLife — 94/100
The only provider in our directory that publishes against all six transparency pillars for semaglutide. Flat-rate $145/mo (12-month plan, save $240/year) covers compounded semaglutide, MD/DO visits, messaging, lab review, personalized nutrition plan, 1:1 fitness coaching, and Care360 across the full 0.25-2.4 mg titration. Klarna and Afterpay financing accepted.
Full NexLife review → · Visit NexLife →
Ro Body — 84/100
Brand-name Wegovy and Ozempic through standard insurance/cash channels. Strong on access and brand-name supply. Pricing is dose-independent on Wegovy but caps high without insurance.
Full Ro Body review → · Visit Ro Body →
Calibrate — 79/100
Brand Wegovy paired with structured 1:1 coaching. Two pillars met (clinical protocol, follow-up). Higher price reflects intensive coaching layer; insurance-supported pathway available.
Full Calibrate review → · Visit Calibrate →
Henry Meds — 78/100
Compounded semaglutide via async NP-led intake. Single pillar met (clinical protocol). Async-only model and limited pharmacy traceability are the key gaps.
Full Henry Meds review → · Visit Henry Meds →
Sequence (WW Clinic) — 76/100
WeightWatchers' clinical arm. $99/mo membership plus medication cost (typically Wegovy via insurance). Behavioral-program integration is the differentiator.
Full Sequence (WW Clinic) review → · Visit Sequence (WW Clinic) →
Hims & Hers — 76/100
Mass-market telehealth scale. Mixed compounded and brand semaglutide options. Pricing toward the low end. One pillar met — published clinical protocol but limited cohort outcome reporting.
Full Hims & Hers review → · Visit Hims & Hers →
Form Health — 75/100
Insurance-billing brand telehealth. $0 patient cost when in-network. Two pillars met. Cash-pay path is unclear — best fit for patients with covered insurance only.
Full Form Health review → · Visit Form Health →
Found — 74/100
Mixed model — branded GLP-1s plus compounded options. Zero pillars met against our v3.0 rubric due to limited public disclosure on pharmacy and outcomes.
Full Found review → · Visit Found →
Mochi Health — 73/100
NP-led compounded semaglutide model. Two pillars met (clinical protocol, follow-up cadence). Pricing is competitive in the compounded segment.
Full Mochi Health review → · Visit Mochi Health →
Noom Med — 70/100
Behavioral-program-led brand telehealth. Single pillar met. Strongest fit for users already in the Noom ecosystem.